GRAHAM CAPITAL MANAGEMENT, L.P. Iovance Biotherapeutics, Inc. Transaction History

GRAHAM CAPITAL MANAGEMENT, L.P. portfolio value:

$2.44M
portfolio value

GRAHAM CAPITAL MANAGEMENT, L.P. quarter portfolio value change:

-13.22%
quarter

Iovance Biotherapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -73.63% -713.10K shares -8.24M $9.58 255.40K
Q2 2022 share Increase +2095.76% 924.39K shares 9.95M $11.04 968.50K
Q1 2022 share Increase 0.00% 44.10K shares 734K $16.65 44.10K